New program aims to boost HIV prevention pill use in eastern europe
NCT ID NCT05323123
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a program to help gay and bisexual men in Romania begin and continue taking PrEP, a daily pill that prevents HIV. The program combined in-person counseling, an educational app, and support from doctors. Researchers wanted to see if this approach was practical and effective in a region where PrEP is not widely used.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PrEP (pre-exposure prophylaxis) medication
What this could lead to
If successful, this program could help more men in Central-Eastern Europe access and use PrEP, reducing new HIV infections in the region.
What could go wrong
This was a small, early feasibility study (120 participants) in one country, so results may not apply broadly. The program's success depends on real-world healthcare systems and individual adherence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University School of Nursing
New York, New York, 10032, United States
-
Romanian Association Against AIDS
Bucharest, Romania
-
Romanian Association Against AIDS
Cluj-Napoca, Romania